• Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Gly1097Val (c.3290_3291delinsTT); Zygosity=Unspecified (PubMed=28356514).
  
• Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Gly618Arg (c.1852G>C); ClinVar=VCV001192236; Zygosity=Unspecified (PubMed=28356514).
  

PubMed=8035614
Annarose Del Mistro, Anna Leszl, Roberta Bertorelle, Maria Luisa Calabro, Marina Panozzo, Chiara Menin, Emma D'Andrea, Luigi Chieco-Bianchi;
A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease.
Leukemia 8:1214-1219(1994)

PubMed=8558920
Wilhelm Gerhard Dirks, Margarete Zaborski, Kathrin Jager, Cecile Challier, Mami Shiota, Hilmar Quentmeier, Hans Gunther Drexler;
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Leukemia 10:142-149(1996)

DOI=10.1016/B978-0-12-221970-2.50457-5
Hans Gunther Drexler;
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=15356658; DOI=10.1038/sj.leu.2403465
Hans Gunther Drexler, Roderick A.F. MacLeod;
Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma.
Leukemia 18:1569-1571(2004)

PubMed=16596703; DOI=10.1002/pmic.200500647
Daniel Cussac, Carole Pichereaux, Audrey Colomba, Florence Capilla, Frederic Pont, Frederique Gaits-Iacovoni, Laurence Lamant, Estelle Espinos, Odile Burlet-Schiltz, Bernard Monsarrat, Georges Delsol, Bernard Payrastre;
Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers.
Proteomics 6:3210-3222(2006)

PubMed=26657151; DOI=10.1038/onc.2015.456; PMCID=PMC4907875
Monica Ceccon, Maria Elena Boggio Merlo, Luca Mologni, Teresa Poggio, Lydia M. Varesio, Matteo Menotti, Silvia Bombelli, Roberta Rigolio, Andrea D. Manazza, Filomena Di Giacomo, Chiara Ambrogio ...Show all 19 authors... , Giovanni Giudici, Cesare Casati, Cristina Mastini, Mara Compagno, Suzanne D. Turner, Carlo Gambacorti-Passerini, Roberto Chiarle, Claudia Voena; Show fewer authors
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.
Oncogene 35:3854-3865(2016)

PubMed=28356514; DOI=10.1073/pnas.1700682114; PMCID=PMC5393253
Jing Chen, Yong Zhang, Michael N. Petrus, Wen-Ming Xiao, Alina Nicolae, Mark Raffeld, Stefania Pittaluga, Richard N. Bamford, Masao Nakagawa, Sunny Tian-Yi Ouyang, Alan L. Epstein ...Show all 16 authors... , Marshall Edward Kadin, Annarose Del Mistro, Richard D. Woessner, Elaine Sarkin Jaffe, Thomas Alexander Waldmann; Show fewer authors
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Proc. Natl. Acad. Sci. U.S.A. 114:3975-3980(2017)

PubMed=29533902; DOI=10.1515/hsz-2017-0321
Hans Gunther Drexler, Claudia Pommerenke, Sonja Eberth, Stefan Nagel;
Hodgkin lymphoma cell lines: to separate the wheat from the chaff.
Biol. Chem. 399:511-523(2018)